- Home
- CRMD vs GAU Comparison
CRMD vs GAU Comparison
Compare CRMD & GAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | GAU |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 605.9M | 680.7M |
| IPO Year | 2009 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CRMD | GAU |
|---|---|---|
| Price | $7.01 | $3.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $15.29 | $3.53 |
| AVG Volume (30 Days) | 1.9M | ★ 3.8M |
| Earning Date | 04-10-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.03 | N/A |
| EPS | ★ 1.97 | N/A |
| Revenue | ★ $43,472,170.00 | N/A |
| Revenue This Year | $627.64 | $87.44 |
| Revenue Next Year | N/A | $25.87 |
| P/E Ratio | $3.57 | ★ N/A |
| Revenue Growth | ★ 66363.08 | N/A |
| 52 Week Low | $5.60 | $1.00 |
| 52 Week High | $17.43 | $3.26 |
Technical Indicators
Market Signals| Indicator | CRMD | GAU |
|---|---|---|
| Relative Strength Index (RSI) | 34.86 | 55.48 |
| Support Level | $7.29 | $2.69 |
| Resistance Level | $7.74 | $3.15 |
| Average True Range (ATR) | 0.32 | 0.22 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 1.99 | 86.58 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About GAU Galiano Gold Inc.
Galiano Gold Inc is focused on building a sustainable business capable of long term value creation for its stakeholders through a combination of exploration, accretive acquisitions, and disciplined deployment of its financial resources. The company currently operates and manages: Nkran, Esaase, Abore and Miradani North, multiple satellite deposits and exploration projects located on the Asankrangwa Gold Belt in the Amansie West District of the Republic of Ghana (Ghana), West Africa.